Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors

E-ISSN： 1875-533x|16|22|2839-2854

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.22, 2009-08, pp. : 2839-2854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

Current Drug Discovery Technologies, Vol. 11, Iss. 2, 2014-06 ,pp. : 113-126

Bentham Science Publishers

Access to resources Recommend Favorite

New phosphatidylinositol 3-kinase inhibitors for cancer

By Bowles Daniel W Jimeno Antonio

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite

The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt

By Gills Joell J Dennis Phillip A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. : 787-797

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of phosphatidylinositol 3-kinase

By Zahradka P.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Research and Development of RAF Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1071-1089

Bentham Science Publishers

Access to resources Recommend Favorite